Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study AT Stopeck, A Lipton, JJ Body, GG Steger, K Tonkin, RH De Boer, ... Journal of clinical oncology 28 (35), 5132-5139, 2010 | 1865 | 2010 |
Intravenous zoledronic acid in postmenopausal women with low bone mineral density IR Reid, JP Brown, P Burckhardt, Z Horowitz, P Richardson, U Trechsel, ... New England Journal of Medicine 346 (9), 653-661, 2002 | 1114 | 2002 |
Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials P Major, A Lortholary, J Hon, E Abdi, G Mills, HD Menssen, F Yunus, ... Journal of clinical oncology 19 (2), 558-567, 2001 | 1034 | 2001 |
Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review A Delvigne, S Rozenberg Human reproduction update 8 (6), 559-577, 2002 | 958 | 2002 |
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice JC Souberbielle, JJ Body, JM Lappe, M Plebani, Y Shoenfeld, TJ Wang, ... Autoimmunity reviews 9 (11), 709-715, 2010 | 773 | 2010 |
Bone health in cancer patients: ESMO Clinical Practice Guidelines R Coleman, JJ Body, M Aapro, P Hadji, J Herrstedt, ... Annals of oncology 25, iii124-iii137, 2014 | 642 | 2014 |
Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates K Fizazi, A Lipton, X Mariette, JJ Body, Y Rahim, JR Gralow, G Gao, L Wu, ... Journal of Clinical Oncology 27 (10), 1564-1571, 2009 | 637 | 2009 |
A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. JJ Body, T Facon, RE Coleman, A Lipton, F Geurs, M Fan, D Holloway, ... Clinical cancer research: an official journal of the American Association …, 2006 | 625 | 2006 |
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel M Aapro, PA Abrahamsson, JJ Body, RE Coleman, R Colomer, L Costa, ... Annals of oncology 19 (3), 420-432, 2008 | 576 | 2008 |
Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases JJ Body, IJ Diel, MR Lichinitser, ED Kreuser, W Dornoff, VA Gorbunova, ... Annals of Oncology 14 (9), 1399-1405, 2003 | 532 | 2003 |
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised … DL Kendler, F Marin, CAF Zerbini, LA Russo, SL Greenspan, V Zikan, ... The Lancet 391 (10117), 230-240, 2018 | 493 | 2018 |
A phase I study of AMGN‐0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases JJ Body, P Greipp, RE Coleman, T Facon, F Geurs, JP Fermand, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 480 | 2003 |
Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases A Lipton, GG Steger, J Figueroa, C Alvarado, P Solal-Celigny, JJ Body, ... Journal of Clinical Oncology 25 (28), 4431-4437, 2007 | 458 | 2007 |
A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1–34)] with alendronate in postmenopausal women with osteoporosis JJ Body, GA Gaich, WH Scheele, PM Kulkarni, PD Miller, A Peretz, ... The Journal of Clinical Endocrinology & Metabolism 87 (10), 4528-4535, 2002 | 455 | 2002 |
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group. JJ Body, R Bartl, P Burckhardt, PD Delmas, IJ Diel, H Fleisch, JA Kanis, ... Journal of Clinical Oncology 16 (12), 3890-3899, 1998 | 449 | 1998 |
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III … JJ Body, IJ Diel, M Lichinitzer, A Lazarev, M Pecherstorfer, R Bell, ... British journal of cancer 90 (6), 1133-1137, 2004 | 419 | 2004 |
Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS) A Delvigne, S Rozenberg Human reproduction update 9 (1), 77-96, 2003 | 404 | 2003 |
Effects of Dairy Products Consumption on Health: Benefits and Beliefs—A Commentary from the Belgian Bone Club and the European Society for Clinical and … S Rozenberg, JJ Body, O Bruyere, P Bergmann, ML Brandi, C Cooper, ... Calcified tissue international 98, 1-17, 2016 | 346 | 2016 |
Bisphosphonates induce breast cancer cell death in vitro O Fromigue, L Lagneaux, JJ Body Journal of bone and mineral research 15 (11), 2211-2221, 2000 | 333 | 2000 |
Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer V Grill, P Ho, JJ Body, N Johanson, SC Lee, SC Kukreja, JM Moseley, ... The Journal of Clinical Endocrinology & Metabolism 73 (6), 1309-1315, 1991 | 321 | 1991 |